DIN 00608203 · ended Jul 8, 2020 · Disruption of the manufacture of the drug.
Showing 12 of 16 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Butalbital Acetylsalicylic Acid Codeine Caffeine. Health Canada has 16 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Butalbital Acetylsalicylic Acid Codeine Caffeine is classified under “OPIOIDS” (ATC N02AA).
Recent changes
Oct 27, 2026
Shortage resolved
Sep 25, 2026
Shortage resolved
Jul 31, 2026
Estimated end date pushed back : Jul 20, 2026 → Aug 20, 2026
Common questions
What is Butalbital Acetylsalicylic Acid Codeine Caffeine used for?
A combination pain reliever containing a barbiturate, ASA, codeine and caffeine, used for tension headaches.
When will Butalbital Acetylsalicylic Acid Codeine Caffeine be back in stock in Canada?
Butalbital Acetylsalicylic Acid Codeine Caffeine has no active shortage; supply is normal per Health Canada reports.
Why is Butalbital Acetylsalicylic Acid Codeine Caffeine in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.